About Cradle Life Sciences
Cradle Life Sciences is a Healthcare company based in Bhilai (India). It operates as a production and distribution of pharmaceutical products in the healthcare sector. The company has 94 employees. Its Indian entity Cradle Life Sciences Private Limited reported revenue of ₹30.86 Cr. Cradle Life Sciences offers products and services including Trust-1 and Mucomol-P Syrup. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Drug Production and Medical Supplies.
Company details
Cradle Life Sciences Pvt. Ltd. was established by medical professionals with a philanthropic focus on healthcare. A wide array of products, including tablets, syrups, and injections, is provided to enhance patient care and accessibility. The organization is recognized for its commitment to quality, cost-effectiveness, and continuous improvement in processes. Locations in New Delhi and Patna support the development and delivery of these items, ensuring they meet diverse medical needs while prioritizing safety and trustworthiness in the sector. Overall, advancements in healthcare solutions are driven through innovative practices.
- Headquarters Bhilai, India
- Employees 94
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Cradle Life Sciences Pvt. Ltd
- Date of Incorporation 08 Dec, 2008
- Jurisdiction Patna, Bihar, India
- Annual Revenue₹30.86 Cr
FY 2025 · +47% YoY
- Net Profit₹98.9 Lakh
FY 2025 · 3% margin
- EBITDA₹2.11 Cr
FY 2025 · 7% margin
- Employee Count94
Associated legal entities of Cradle Life Sciences
Cradle Life Sciences operates through Cradle Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cradle Life Sciences Private Limited CIN U24232BR2008PTC014097 | Active | 08 Dec 2008 | Patna, Bihar | ₹30.9 Cr | 94 | 8 | View details |
Products & Services of Cradle Life Sciences
Cradle Life Sciences offers a comprehensive portfolio of products and services, including Trust-1 and Mucomol-P Syrup.
Trust-1 is produced as a pharmaceutical tablet for healthcare applications.
This syrup is manufactured for medical use in addressing healthcare needs.
Board of directors of Cradle Life Sciences Private Limited (Cradle Life Sciences)
Cradle Life Sciences Private Limited is the primary company behind Cradle Life Sciences. The board of Cradle Life Sciences Private Limited currently have 8 directors; the longest-serving is Sanjiv Sinha, appointed in 2008. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjiv Sinha DIN 02405350 | Director | 08 Dec 2008 | 17 yrs 10 mo | Cradle Life Sciences Private Limited |
| Rajnish Pandey DIN 02364709 | Director | 08 Dec 2008 | 17 yrs 10 mo | Cradle Life Sciences Private Limited |
| Prashant Dubey DIN 02140531 | Director | 08 Dec 2008 | 17 yrs 10 mo | Cradle Life Sciences Private Limited |
| Satish Kumar Pandey DIN 02304134 | Director | 08 Dec 2008 | 17 yrs 10 mo | Cradle Life Sciences Private Limited |
| Ranjan Kumar DIN 02451620 | Director | 18 Dec 2008 | 17 yrs 10 mo | Cradle Life Sciences Private Limited |
| Vivek Anand DIN 02451610 | Director | 18 Dec 2008 | 17 yrs 10 mo | Cradle Life Sciences Private Limited |
| Mani Pandey DIN 05120809 | Director | 10 Nov 2011 | 14 yrs 11 mo | Cradle Life Sciences Private Limited |
| Rolly Kumari DIN 09054919 | Director | 11 Mar 2021 | 5 yrs 7 mo | Cradle Life Sciences Private Limited |
Financials of Cradle Life Sciences
Figures of Cradle Life Sciences Private Limited, the primary company behind Cradle Life Sciences, for FY 2025. Revenue was ₹30.86 Cr (+47% year on year). Net profit was ₹98.9 Lakh (3% margin). EBITDA was ₹2.11 Cr (7% margin). Revenue has grown at a compounded annual rate of +40% over three years and +15% over five years.
- ₹30.86 CrRevenue · FY 2025 · +47% YoY
- ₹98.9 LakhNet profit · 3% margin
- ₹2.11 CrEBITDA · 7% margin
- ₹19.1 LakhPaid-up capital
- 94Employees (provident fund records)
- +40%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cradle Life Sciences Private Limited are on its company page.
Detailed financial statements for Cradle Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Cradle Life Sciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cradle Life Sciences
Cradle Life Sciences is headquartered in Bhilai, India. It is registered at Bhilai, Chhattisgarh, India.
Cradle Life Sciences has 94 employees.
The primary company behind Cradle Life Sciences, Cradle Life Sciences Private Limited, reported revenue of ₹30.86 Cr for FY 2025, up 47% year on year.
Cradle Life Sciences Pvt. Ltd. was established by medical professionals with a philanthropic focus on healthcare. A wide array of products, including tablets, syrups, and injections, is provided to enhance patient care and accessibility. The organization is recognized for its commitment to quality, cost-effectiveness, and continuous improvement in processes. Locations in New Delhi and Patna support the development and delivery of these items, ensuring they meet diverse medical needs while prioritizing safety and trustworthiness in the sector. Overall, advancements in healthcare solutions are driven through innovative practices.
Cradle Life Sciences offers Trust-1 and Mucomol-P Syrup.
Cradle Life Sciences operates through Cradle Life Sciences Private Limited.
The legal entities of Cradle Life Sciences currently have 8 directors, including Rolly Kumari, Ranjan Kumar, Sanjiv Sinha and others.